BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 11, 2002
View Archived Issues
GSK describes ALK5 inhibitors with potential in renal diseases, etc.
Read More
The PPAR coagonist LY-465608 reduces progression of atherosclerotic lesions
Read More
Ritonavir reported to have antineoplastic effects against Kaposi's sarcoma
Read More
FDA approves pivotal periodontal surgery trial of dermal substitute
Read More
CIMA announces first European launches of Remeron SolTab
Read More
Micrologix and Fujisawa to codevelop and commercialize MBI-226
Read More
Promising preclinical and early clinical findings reported this week for RSD-1235 at IUPHAR 2002
Read More
Capravirine not associated to date with an increased risk of vasculitis in the clinic
Read More
RS-1178 specifically attenuates Abeta-induced macrophage activation
Read More
Novel spin-trapping agent shows promise for neurodegenerative disorders
Read More
RS-0406 presented as novel beta-sheet breaker with potential in Alzheimer's disease
Read More
Alleviation of neuropathic pain demonstrated for NO-releasing gabapentin derivative
Read More
GT-015 superior to glyceryl trinitrate in cardioprotective efficacy in isolated rat hearts
Read More
Fast-track AIDS drug T-20 highlighted at the 14th International AIDS Conference
Read More
Potential role of the combination of orlistat and fluvastatin in obesity
Read More
New data on ezetimibe presented at the EAS congress
Read More
Potential use of a combination of two recombinant adenoviral vectors in cancer gene therapy
Read More
Kyorin patents new immunosuppressant proteasome inhibitors
Read More
Novel histamine H3 modulators for AD and other disorders
Read More
Bayer PARP inhibitors with potential in ischemia-reperfusion injury
Read More
New steroid 17-20 lyase inhibitors identified by Takeda R&D team
Read More
Biovitrum presents novel 5-HT2C ligands for use in obesity and other conditions
Read More
Selective alphav integrin antagonists in early development at Merck
Read More